Stöd NewsVoice så att vi säkrar verksamheten tom juni!

40%

40.000 kr av behovet 100.000 kr är insamlat. Stöd kampanjen via Swish 123 530 2005 eller donera på ett annat sätt. Det smartaste för företag är att annonsera. Uppd. 23/4 kl 09:30.

Media pushes success of GSK malaria vaccine while ignoring deadly side effects

NewsVoice is an online news and debate channel that started in 2011. The purpose is to publish independent news, debate articles and comments as well as analyzes.
publicerad 23 oktober 2011
- News@NewsVoice
Stickmygga (Culiseta longiareolata). Foto: Alvesgaspar. Licens: CC BY-SA 3.0, Wikimedia Commons

NATURAL NEWS. “Mainstream media is excited over GlaxoSmithKline’s latest offering, a malaria trial vaccine that the company claims can cut the risk of clinical and severe malaria in children by 56% and 47%, respectively. But what GSK and the media do not report are the vaccine’s deadly side effects.

Bill & Melinda Gates Foundation suggest that children who receive three doses will have additional protection against malaria when used in conjunction with other disease control methods. But the findings also show that vaccinated children are at a high risk of serious injury or death as well.”

Learn more


Du kan stötta Newsvoice via MediaLinq

Tags: vaccin